Elzonris is a recombinant protein consisting of human interleukin-3 (IL-3) conjugated with diphtheria toxin that is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm. This protein binds to the IL-3 receptor subunit alpha chain (CD123), preventing protein synthesis and prompting cell death.

If you have a Hayes login, click here to view the full report on the Knowledge Center.